Diabetes Drugs: Summary of Recommendations
- Full Report (460k PDF)
- 2-Page summary (463k PDF)
- Easy-to-read: Diabetes booklet (982k PDF)
- Folleto sobre la Diabetes, fácil de entender (992k PDF)
- Download Adobe Acrobat Reader
- Newer drugs are no better. Two drugs from a class called the sulfonylureas and a drug named metformin have been around for more than a decade and work just as well as newer medicines. Indeed, several of the newer drugs are less effective than the older ones.
- Newer drugs are no safer. All diabetes pills have the potential to cause adverse effects, both minor and serious. The drugs' safety and side effect "profiles" may be the most important factor in your choice.
- The newer drugs are more expensive. The newer diabetes medicines cost many times more than the older ones.
- Taking more than one diabetes drug is sometimes necessary. Many people with diabetes do not get enough blood sugar control from one medicine. Two or more may be necessary. However, taking more than one diabetes drug raises the risk of adverse effects and increases costs.
- Metformin - alone or with glipizide or glimepiride
- Glipizide and Glipizide Sustained Release - alone or with metformin
- Glimepiride - alone or with metformin
These medicines are available as low-cost generics, costing from $10 to $60 a month. If you have been diagnosed with diabetes, we recommend that you try metformin first unless your health status prevents it.
If metformin fails to bring your blood sugar into normal range, we recommend you add glipizide or glimepiride. Should either of those cause problems, Actos (pioglitizone) may be an option you and your doctor will want to consider. Be aware that Actos has been linked to a higher risk of heart failure.
Diabetes Drugs: Drug Comparison
* For space reasons, not all doses are listed.
1. As commonly or usually recommended.
2. Prices reflect nationwide retail average for September 2008, rounded to the nearest dollar. Information derived by Consumer Reports Best Buy Drugs from data provided by Wolters Kluwer Health, Pharmaceutical Audit Suite®. Wolters Kluwer Health is not involved in our analysis or recommendations.
1. As commonly or usually recommended.
2. Prices reflect nationwide retail average for September 2008, rounded to the nearest dollar. Information derived by Consumer Reports Best Buy Drugs from data provided by Wolters Kluwer Health, Pharmaceutical Audit Suite®. Wolters Kluwer Health is not involved in our analysis or recommendations.
- Full Report (460k PDF)
- 2-Page summary (105k PDF)
- Easy-to-read: Diabetes booklet (982k PDF)












